UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D. C. 20549
____________
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
September
21, 2009
Date of Report (Date of earliest event
reported)
SAFESTITCH
MEDICAL, INC.
(Exact
Name of Registrant as Specified in Charter)
|
Delaware
|
0-19437
|
11-2962080
|
||
|
(State
of Other Jurisdiction
|
(Commission
File Number)
|
(I.R.S.
Employer
|
||
|
of
Incorporation)
|
Identification
Number)
|
|
4400
Biscayne Boulevard, Suite A-100, Miami, Florida
|
33137
|
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
(305)
575-4145
(Registrant’s
telephone number, including area code)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
|
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR
240.13e-4(c))
|
|
Item
7.01
|
Regulation
FD Disclosure
|
Beginning
September 21, 2009, senior executives of SafeStitch Medical, Inc. (the
“Company”), will present the slides and additional financial information
attached as Exhibit 99.1 to this Current Report on Form 8-K (the “Presentation”)
at the UBS Global Life Sciences Conference in New York City. A copy
of the Presentation is attached hereto as Exhibit 99.1 and is incorporated by
reference in this Item 7.01.
The
information in this Current Report on Form 8-K (including Exhibit 99.1) is
“furnished” and shall not be deemed “filed” for purposes of Section 18 of
the Securities Exchange Act of 1934, as amended, or otherwise subject to the
liabilities of that section, nor shall it be deemed to be incorporated by
reference in any filing by the Company under the Securities Act of 1933, as
amended. The information in this Current Report on Form 8-K shall not
be deemed an admission as to the materiality of any information required to be
disclosed solely to satisfy the requirements of Regulation FD.
|
Item
9.01
|
Financial
Statements and Exhibits
|
|
Exhibit Number
|
Description
|
|
|
99.1
|
Presentation
materials to be given at the UBS Global Life Sciences Conference,
September 21-23,
2009.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
|
SAFESTITCH
MEDICAL, INC.
|
|||
|
By:
|
/s/ Adam S. Jackson
|
||
|
Name: Adam
S. Jackson
|
|||
|
Title:
Chief Financial Officer
|
|||
Date:
September 21, 2009
Exhibit
Index
|
Exhibit Number
|
Description
|
|
|
99.1
|
Presentation
materials to be given at the UBS Global Life Sciences Conference,
September 21-23,
2009
|
